chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My daughter had a low grade fever on july 2nd. She awoke that night (about 1 am) and had a seizure which lasted at least 3 minutes. We called 911 and she was taken to the emergency room. We were told that she had a febrile seizure, which had never happened before. I asked if it could be related to the vaccines she received a few days earlier and was told no, it was too long afterward (it had been about 4 days). She continued to run a fever above 100 degrees for the next 3 days. I took her to the pediatrician for a follow-up on July 4th since the fever had not broken. I asked again if it could be a vaccine reaction and again was told no. They screened her for a urinary tract infection (negative) and examined her for other signs of viral infection. None were found. They next day (7/5) she woke up with a red rash covering her entire torso. By evening it had spread to her face and bottom and became very itchy/uncomfortable for her. I took her in for a second follow up and stated that I was frustrated that this was pretty clearly a reaction to the vaccine (all of her symptoms from seizure to rash can be linked to the mmr vaccine per online sources). Again the doctor said it was possible but unlikely and that perhaps she had contracted rosacea (??!) At this time she has been fever free for about 36 hours and has had a rash for 48 hours. The rash now covers her entire body from head to toe and is itchy to the point that she is uncomfortable in clothes or a diaper and has difficulty sleeping.
1/17/2022 Patient presented for chief complaint of fatigue with generalized weakness and bilateral lower extremity weakness for the past 3-4 months. Patient has additionally been drinking every other day and has not been compliant with his medications. He was found covered in feces by EMS. He was acidotic and found to be positive for Covid-19 on presentation.  For his Covid-19, patient was not hypoxic and did not require dexamethasone. He was started on ceftriaxone and doxycycline for possible superimposed bacterial pneumonia.
The pt reports that within 24 hours the left arm was swollen, hot and red from the elbow to the shoulder, "one huge hive" and extreme itching. The family MD was not available and the Pt went to the ER. Treated with Prednisone and Atarax for itching.
HEART PALPITATIONS; WEAKNESS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk and expiry date: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced heart palpitations, and weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart palpitations, and weakness. This report was non-serious. This case, from the same reporter is linked to 20210856064.
Patient completed wait after vaccine with no complications.  Approximately 1.5 hours after vaccination noted rash to arms and legs while feeling well with no distress or itching. Returned to vaccine site. Vss. Continued to feel completely well. Urticaria noted to forearms and calves. Face and torso clear. Reported 3 episodes of urticaria since first covid vaccine. Oral benadryl given. Urticaria faded. PT has started to use a new body wash. All rashes have occurred since that change.  D/c'd home with family.  Advised re rest, fluids and additional benadryl prn. Call md/911/ er if increased problems  or concerns.
having trouble breathing; This is a spontaneous report from a Pfizer-sponsored program Support. A contactable consumer reported for a patient (Reporter's wife) that.  A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: not reported) via an unspecified route of administration on 27Apr2021 as dose 2, single for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. Reporter stated his wife who got second dose on 27Apr2021 (today) and was having trouble breathing. She wanted to know if it was something that he should be worried about. There were unaddressed medical questions referred or forwarded to Medical Information. Outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be required.
Took the first 3 doses according to schedule and took the final dose on the 11th day after the third dose; A spontaneous report was received from the registered nurse on 23JUN2022. It described an 18-year-old male patient who "took the first 3 doses according to schedule and took the final dose on the 11th day after the third dose" (PT: Inappropriate schedule of product administration). The patient took the Vivotif (typhoid vaccine live oral Ty21A) (lot number: unknown) for immunisation. It was reported that the patient received Vivotif from the clinic on 29MAY2022 and started taking the vaccine approximately one week later. Reportedly, the patient took the first three doses according to the schedule on days 0, 2, and 4 and forgot to take the final dose on the scheduled day but took it on the 11th day after the third dose. Additionally, the vaccine was maintained at appropriate temperature in the patient's refrigerator.  Action taken with Vivotif with respect to the reported event was not applicable.  The outcome of the reported event was unknown.  No additional information was reported.  Company comment: It was reported that a consumer took the first 3 doses of Vivotif according to schedule and took the final dose on the 11th day after the third dose (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event.; Sender's Comments: It was reported that a consumer took the first 3 doses of Vivotif according to schedule and took the final dose on the 11th day after the third dose (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event.
Varicella - information has been received from a healthcare professional concerning a 6 year old female who on 26 aug 1996 was vaccinated with one dose of varicella virus vaccine live (site unkown) on 11 apr 2000 the patient experienced full blown chicken pox, greater than 200 lesions.  In follow up information from a healthcare professional it was reported that to her knowledge, the child was doing well and had no complications to date from the chickenpox.  The patient does have a pretty severe case of chickenpox, with at least several hundred generalized lesions.  The reporter stated that she had not spokken with the child's mother in several days.  so she does not really have any additonal case information to add, nor does she have any knowledge about a history of recent varicella exposure.  With respect to the patient's history the reporter stated that the child has asthma, and has a history of intermittent steroid use.  The child was most recently started on steroids in february, 2000.  The child also uses Albuterol on a routine basis.  follow up information form a registered nurse indicated that the patient was not a steroids at the time of vaccination or within 2 weeks before or after vaccinateion,  It was reported that a specimen was obatined for analysis but was accidentally discarded.  Subsequently, the patient completely recovered.
VERY FATIGUED, LOSS OF APPETITE, CHILLS, HEADACHE, FEVER X 3 DAYS AFTER SHOT, VARIOUS OTHER JOINT SND MUSCLE PAINS SINCE. NOT ABLE TO BEAR WEIGHT ON RT LEG, KNEE HURTING WITH WEIGHT. ANKLE SWELLING ON RT SIDE. BACK NECK SPINE PAIN. INSOMNIA, 1SAT DAY AFTER SHOT, 1ST BOWEL MOVEMENT HAD RED BLOOD IN IT, NOW HAS MORE MUCUS THAN NORMAL.
noc following vax pt had fever of 102.2 before APAP, c/o cough & sore throat lt deltoid @ site of DTP became red swollen to softball size; grandma gave APAP w/good effects of reduced soreness & fever;
Given a DTaP and IPV intramuscularly into the right arm on 5/20/03.  He developed itching soon after and then firmness, swelling.  No pain.  He has had itching since.  No spread of itching.  No previous reactions to immunizations.  No fever.
Patient feeds racoons daily off his back deck and has for years.  Initial 3 shot rabies series here 5-6 years ago.  In 2001 had animal contact while feeding racoons and took 2 dose follow up rabies vaccine.  Then 11/03/2003 presented to health department with another encounter-racoon bit his big toe.  Referred to PCP for evaluation and treatment.  Rabies Imovax administered on 11/03/2003 and 11/06/2003 as preventative.  11/12/2003 phone call from client.  He states broke out in hives 11/11/2003.  Referred to PCP for evaluation. Discussed possible hypersensitivity to Imovax.  Instructed to discontinue all contact with wild animals.
Papular, round, red pruritic rash on body accompanied by fever and lethargy. Fever and lethargy resolved after 72 hours. Rash has been slowly resolving.
Developed severe chills/sweating 48 hours after vaccine. Afebrile. Was seen in urgent care, found to be tachycardic and sent to ER for further eval. Blood work showed pancytopenia. Negative for COVID, paro, and flu. No other cause for pancytopenia identified. Patient remain pregnant and was told baby is doing fine.
Adverse effect started as a severe back pain, not like a pulled muscle or slipped disk, but deeper than that. It didn't hurt with lateral movement or bending. It really hurt if I was driving and hit a bump. After about 30 days the back pain went away but then my right knee started to hurt to the point that I couldn't bend it. After about 15 days it started to get better but then my left knee started to hurt to the point where I couldn't bend it. Doctor took x-rays and said I had early stages of arthritis. Gave me a shot of cortisone in my left knee (said it showed as worst in x-rays). Left Knee feels better now (3 days after shot) right need still has some pain.  Never had any issues with my knees or back prior to the vaccine.
Information has been received from a consumer concerning her son, a 26 month old male, who on approximately 21 November 2004 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On 29 January 2006, the patient developed nasal congestion. On 31 January 2006, the patient developed a fever of 101 degrees F, irritability, and a raised rash. One lesion was the size of a quarter. The physicians office was contacted, and based on the consumers description, the staff at the physician's office felt that the child had developed chickenpox. The patient had not been seen in the physicians office, but he was treated with Diphenhydramine hydrochloride (Benadryl) (1.5 tsp twice and q6h through 01 February 2006) and acetaminophen (Jr Tylenol Meltaways). He was awake and restless overnight through the early morning hours of 01 February 2006. On 01 February 2006, there was still no blistering or pimple like bumps, but the rash was from head to toe and extremely itchy. He was treated with pramoxine hydrochloride (+) zinc acetate (Caladryl Clear). He was examined by the physician on 01 February 2006 and it was determined that he had some type of viral exanthem. The fever was gone by the evening of 01 February 2006. The rash was completely gone by Saturday, 04 February 2006. Additional information is not expected.
This case was reported by a nurse and described a 41 year old female pt who did not respond to Engerix-B. On unspecified dates, the pt received the Engerix-B "series". On an unspecified date in 2004, a hepatitis B surface antibody titer was "Negative".
Left arm very sore when moved in front of body, immediately after waking up next day. Arm stayed sore about all day, ate partial breakfast, felt a bit nauseous, quit eating, then OK. Had chills til about 5 pm, no energy, temperature of 98.8F. Just sat, did nothing most of day.
The injury was catastrophic. It took away my ability to walk and I'm having breathing problems and lung issues - inability to walk, shortness of breath and significantly increased brain fog/damage. I am mostly bed ridden.
Three days after I received the vaccine I got my period. It has now been 6 days and I still have my period. Usually my period is between 2-4 days (max). It has been heavy and bright red this entire time.
the patient had gotten one and had gotten the flu; Initial information regarding this unsolicited valid non-serious social media case received from a patient and transmitted to Sanofi on 05-Nov-2020.  This case involved a patient of unknown demographics who had gotten one INFLUENZA VACCINE and had gotten the flu (influenza).  Relevant medical history, past medical treatment, vaccination details, concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) unknown latency following the administration of INFLUENZA VACCINE. It was reported that the patient was healthy as a horse if the patient did not get it.  Relevant laboratory test was not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.
Tdap was given instead of Td.  Pt was 65 years of age when the Tdap was administered. There was no adverse event.
After receiving his vaccine at 1020, patient c/o dizziness and lightheadedness at 1037, reporting he had similar mild side effects with the first dose.  VS monitored, initially exhibiting elevated BPs.   The following VS were obtained throughout monitoring: 1037 BP149/85, HR 69, O2 Sats 100% 1040 BP 133/67, HR 70, O2 sats 100% 1043 BP135/67, HR 75, O2 sats 100% 1048 BP 133/72, HR 73, O2 sats 99% 1055 BP 131/72, HR 69, O2 sats 97% 1105 BP 122/77, HR 67, O2 sats 97% Patient was given a bottled water.  No meds given.  Patient just monitored for extra minutes with final VS as follows: BP 122/77, HR 67, O2 sat 97%.  Pt discharged in stable condition accompanied by spouse.
Itchy Throat 30 minutes after, throat swelling reported and hour later, SOB.
Possible late 2nd dose; This non-serious case was reported by a other health professional via sales rep and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Possible late 2nd dose).  The outcome of the drug dose administration interval too long was unknown.   Additional Information: Receipt date: 23-AUG-2023 Possible late 2nd dose reported on behalf of provider by sales representative. The vaccine administration facility is the same as primary reporter. No other adverse event (AE) details made available. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.
pt devel paleness, cyanosis & muscle tone loss approx 5 hrs p/immun; pt recovered;
Patient was administrated with Pediarix an extra dose of Sanofi IPV; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 3-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 5n259, expiry date 5th October 2023) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis and POLIOMYELITIS VACCINE INACTIVATED (IPV VACCINE) for prophylaxis.   On 17th May 2022, the patient received the 1st dose of Pediarix, Pediarix Pre-Filled Syringe Device and IPV VACCINE. On 17th May 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 17-May-2022 Reporter's comments: Medical assistance reported that the patient was administrated with Pediarix and an extra dose of Sanofi IPV vaccine on same day. No adverse event was reported. The vaccine administration facility was the same as primary reporter. The consent to follow up was given. Additional Supportive Information: The patient received Pediarix and an extra dose of Sanofi IPV vaccine on same day, which led to overdose.
Fever, body chills, body aches, headache, nausea, swelling and pain (8/10) in injection site and underarm (likely lymph node swelling)
Patient initially reported dizziness following vaccination. Then called patient on 6/9 at 4:45pm and she reported that she's in the hospital and being checked as her whole body hurts. She reports symptoms of headache, body aches, and sore throat.
This spontaneous report as received from a physician refers to an 18 year old female patient. On 24-AUG-1998 the patient was vaccinated with the first dose of MMR II (lot number, dose, route not reported). Concomitantly on 24-AUG-1998 the patient was vaccinated with the fourth dose of DTP/Hib. On 14-MAR-2000 the patient was vaccinated with the second dose of MMR II (lot number, dose, route not reported). The patient's prior vaccination history included three doses of poliovirus vaccine (unspecified) (first dose on 27-FEB-1995, second dose on 27-APR-1995 and third dose  on 24-AUG-1996) and three doses of DTP/Hib (first dose on 27-FEB-1995, second dose on 27-APR-1995, third dose on 24-JUL-1995). The patient was vaccinated with the fifth dose of DTP/Hib on approximately 1999, when she was 5 year old. It was reported that the patient underwent antibody tests (non fasting). The specimen was collected on 21-AUG-2013 at 09:16 (date of report: 22-AUG-2013). The mumps virus antibody (IgG) test was negative and showed 0.6 AI LO which indicated that the patient was non-immune. Other tests performed from the same sample were: rubeola/measles (IgG) 4.9 AI (immune); varicella zos.. (IgG) 3.1 AI (immune); Rubella, IgG 94.2 IU/mL (immune). The outcome of Mumps virus antibody test negative was not reported. It was stated that nothing would be done unless the patient wants another MMR vaccine for school. This is one of several reports received from the same source (linked MARRS#s: 1309USA012393, 1310USA006775, 1310USA006778).  Additional information has been requested.
Skin rash of small red spots over body, most densely populated on hands, cheeks, and ears.
Contracted COVID after having received both doses of Pfizer Covid Vaccine; Contracted COVID after having received both doses of Pfizer Covid Vaccine; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program COVAX Support. The reporter reported same event for both him and his wife. This is the first of two reports. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 on an unspecified date (Batch/Lot number was not reported), dose 2 on 30Jan2021 (Batch/Lot number was not reported), both via an unspecified route of administration as single dose as for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced contracted covid after having received both doses of pfizer covid vaccine in Jul2021 with outcome of unknown. Information about lot and batch number was requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021887202 Same reporter and drug, different patient
I had the usual arm pain, fatigue but within a couple weeks I had severe joint and muscle pain, especially in my legs. I started throwing up occasionally. The pain continued for quite some time, it was very hard to stand up, my legs felt like wood. I made an appt with an Orthopaedic surgeon to get cortisone shots in my knees so I could walk a little better. By the time I reached the main door I was sweating and a little groggy. I sat on a bench by the door because I couldn?t walk more. I was still sweating, burning up, and groggy. Then it felt like I had a thousand bees stinging me and it was difficult to breathe. My heart was pounding and I didn?t know if I was having a heart attack or anaphylaxis. After about an hour I was able to make my way to the car where I sat for at least another hour. The fever I was feeling changed to frigid cold, as I drove home I had the seat heaters and car heaters on, in July. When I got home I turned the ax off, the heat in, and climbed into bed entirely under the blankets, with all my clothes on and shook from the cold for a few hour. Not shivering- shaking. It subsided after awhile. I am used to cortisone and never had reactions. I also had my titers checked and they were >2500.  Although I am a blood cancer and BMT survivor I will not get the moderna booster.
He came home, laid down and went to sleep and slept all day long.  He had incontinence or urine, and could not put any weight on his legs, could not stand on his own and confused about what was going on.  His wife was able to get him up after pulling and tugging on him, and mentally confused.  He was able to go to the bathroom, and got him back to bed.  He had a urinary accident and slept until the evening.  She could tell he was better and walked with a walker.  She said the symptoms resembled a stroke, but he got better.   He did not take anything, did not want anything for the symptoms.  She does not think that he ate anything that night.  He says that he's fine  now.
Ringing in ear. Worse at night, sleeping, but constant. Also happened after first dose in March 2021
Patient reports fever, chills, body aches, and nausea starting the evening she received the shot.  She used a combination of OTC acetaminophen and ibuprofen to treat the symptoms and reports feeling better later that night.  She reports feeling more tired than usual on 11/10/2020 and 11/11/2020
fever to 105.1 F, body aches. Developed day after vaccination. Presented to ED nearly 24 hours after vaccination.
9/19/11 12pm FLUZONE administered. 9/19/11 3pm: achy, weakness, sore throat, cough, headache. 6pm: sweating, chills, increased aching, fever 102.9. 7:30pm: Took 2 ADVIL and went to bed sxs resolving.